Table 3.

Completed cases and reasons of discontinuation

	BNS01 study	BNS02 study
	N = 321	N = 61
Dose of BNS
Mean final dose [SD] (mg/day)	13.0 [6.7]	12.8 [6.1]
Mean maximum dose [SD] (mg/day)	14.8 [7.2]	14.0 [6.1]
Completed cases
Week 28 completed, n (%)	264 (82.2)	48 (78.7)
Weeks 28–52 completed, n (%)	93 (29.0)	3 (4.9%)
Weeks 52–56 completed, n (%)	155 (48.3)	38 (62.3)
Mean treatment duration [SD] (day)	268.2 [123.2]	301.9 [126.5]
Concomitant use
Antipsychotic drugs	286 (89.1)	17 (27.9)
Antiparkinsonian drugs	299 (93.1)	55 (90.2)

BNS blonanserin, SD standard deviation